Recommendations on TNFα inhibitor biosimilar use in clinical practice: a comparison of European gastroenterology IBD guidance

Rosanne W. Meijboom; Liese Barbier; Louise C. Druedahl; Kati Sarnola; Hanna M. Tolonen; Helga Gardarsdottir; Acg Egberts; Thijs J. Giezen

doi:10.1080/14712598.2023.2189008

Recommendations on TNFα inhibitor biosimilar use in clinical practice: a comparison of European gastroenterology IBD guidance

Rosanne W. Meijboom, Liese Barbier, Louise C. Druedahl, Kati Sarnola, Hanna M. Tolonen, Helga Gardarsdottir, Acg Egberts, Thijs J. Giezen

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Journal	Expert Opinion on Biological Therapy
Volume	23
Issue number	8
Pages (from-to)	801-817
Number of pages	17
ISSN	1471-2598
DOIs	https://doi.org/10.1080/14712598.2023.2189008
Publication status	Published - 3 Aug 2023
MoE publication type	A1 Journal article-refereed

Fields of Science

Biosimilar
Gastroenterology
Guidelines
Inflammatory bowel disease
Infliximab
Switching
Tumor necrosis factor inhibitors
317 Pharmacy

Access to Document

10.1080/14712598.2023.2189008

Recommendations on TNF inhibitor biosimilar use in clinical practice a comparison of European gastroenterology IBD guidanceFinal published version, 2.33 MBLicence: CC BY-NC-ND

Cite this

@article{86ef8fba904b4c16b79d21bf49e1bb5a,

title = "Recommendations on TNFα inhibitor biosimilar use in clinical practice: a comparison of European gastroenterology IBD guidance",

keywords = "Biosimilar, Gastroenterology, Guidelines, Inflammatory bowel disease, Infliximab, Switching, Tumor necrosis factor inhibitors, 317 Pharmacy",

author = "Meijboom, \{Rosanne W.\} and Liese Barbier and Druedahl, \{Louise C.\} and Kati Sarnola and Tolonen, \{Hanna M.\} and Helga Gardarsdottir and Acg Egberts and Giezen, \{Thijs J.\}",

year = "2023",

month = aug,

day = "3",

doi = "10.1080/14712598.2023.2189008",

language = "English",

volume = "23",

pages = "801--817",

journal = "Expert Opinion on Biological Therapy",

issn = "1471-2598",

publisher = "Taylor and Francis Ltd.",

number = "8",

}

TY - JOUR

T1 - Recommendations on TNFα inhibitor biosimilar use in clinical practice

T2 - a comparison of European gastroenterology IBD guidance

AU - Meijboom, Rosanne W.

AU - Barbier, Liese

AU - Druedahl, Louise C.

AU - Sarnola, Kati

AU - Tolonen, Hanna M.

AU - Gardarsdottir, Helga

AU - Egberts, Acg

AU - Giezen, Thijs J.

PY - 2023/8/3

Y1 - 2023/8/3

KW - Biosimilar

KW - Gastroenterology

KW - Guidelines

KW - Inflammatory bowel disease

KW - Infliximab

KW - Switching

KW - Tumor necrosis factor inhibitors

KW - 317 Pharmacy

U2 - 10.1080/14712598.2023.2189008

DO - 10.1080/14712598.2023.2189008

M3 - Article

C2 - 36947408

SN - 1471-2598

VL - 23

SP - 801

EP - 817

JO - Expert Opinion on Biological Therapy

JF - Expert Opinion on Biological Therapy

IS - 8

ER -